Prostate Cancer

Latest News

Trial expands to evaluate ORIC-944 with AR inhibitors in prostate cancer
Trial expands to evaluate ORIC-944 with AR inhibitors in prostate cancer

July 17th 2024

ORIC-944 was initially being evaluated as a monotherapy in the phase 1b trial.

Adding darolutamide to ADT extends rPFS in mHSPC
Adding darolutamide to ADT extends rPFS in mHSPC

July 17th 2024

Dosing, enrollment progress in phase 1/2 study of ONCT-534 in mCRPC
Dosing, enrollment progress in phase 1/2 study of ONCT-534 in mCRPC

July 15th 2024

Neighborhood disadvantage linked to stress-related genes that may increase prostate cancer risk
Neighborhood disadvantage linked to stress-related genes that may increase prostate cancer risk

July 12th 2024

CMS issues category 1 CPT codes for TULSA procedure
CMS issues category 1 CPT codes for TULSA procedure

July 11th 2024

Video Series
Video Interviews
Podcasts
medical depiction of prostate cancer
Urology Times Speaking of Urology® logo

More News

© 2024 MJH Life Sciences

All rights reserved.